© 2026 Nanjing Finechem Holdings Co., Ltd,
All Right Reserved
Protein engineering opened up in unexpected ways once Sortase A entered labs. Isolated from Staphylococcus aureus, this enzyme quickly shifted from a curiosity in bacterial physiology to a celebrated tool in bioconjugation. Discovery stories from the late 1990s painted a picture of scientists piecing together how Gram-positive bacteria anchor surface proteins, almost by accident finding Sortase A’s transpeptidase activity. As word spread, researchers recognized just how specific its LPXTG recognition was, providing a controlled way to modify proteins—a major leap compared to vague and sometimes uncontrollable chemical labeling strategies. Over the next two decades, Sortase A went from obscurity to a mainstay in toolkits of molecular biologists, tightly linked with the rise of antibody drug conjugates, cell surface engineering, and biosensor design.
Sortase A with a His-tag stands out for its fusion of easy purification and consistent activity. This enzyme, recombinantly expressed, often in E. coli, lets labs produce clean, active protein without the headaches of contamination or misfolding that plagued earlier days. The His-tagged version magnets right onto nickel affinity columns, saving time and reagents. Its reliable handling means more groups can take on creative bioconjugation projects, even if enzyme purification feels new. For anyone tinkering with protein labeling, Sortase A’s His-tag variant offers straightforward purification, predictable activity, and a clear entry into site-specific modification experiments.
If you’ve worked with Sortase A, you probably noticed its neat, compact structure. This protein, usually clocking in at about 20 to 25 kDa, stays stable in buffered saline at slightly alkaline pH. Its most celebrated feature—selectivity for the LPXTG motif—sets it apart from blunt chemical labeling that splatters modifications across a protein’s surface. Sortase A has a catalytic cysteine at its core, and its flexibility at room temperature means you don’t need special chambers or exotic reagents. Enzyme stability, though, remains a watch point: freeze-thaw cycles can affect activity, so small aliquots prevent disappointment. Fresh enzyme always gives sharper results during peptide or protein ligation.
One key reason labs return to Sortase A is clarity in its labeling. This His-tagged enzyme usually comes with batch-specific certifications for activity, purity, and absence of contaminants like DNase and RNase. Vendors sometimes provide detailed activity assays, but many labs run their own controls using FRET-based peptides or labeled LPETG substrates, measuring the true specific activity in-house. If you’re fussy about trace metals or buffer components, opt for higher-grade preparations. The ease of spotting the His-tag by antibody or Ni-NTA resin adds another layer—making it a favorite in both protein purification and downstream analysis.
Producing good Sortase A depends on recombinant expression in E. coli, followed by nickel affinity purification. Most protocols rely on IPTG induction for robust expression, then lyse cells by sonication or pressure. After cell lysis, clarified supernatants bind to Ni-NTA resin, followed by elution with imidazole. Extra rounds of size-exclusion chromatography remove aggregates or nonspecific bands. Some groups stick to rapid methods, turning out usable enzyme in 24 hours. Others slow down, focusing on precise folding. A major trick is making small aliquots and storing at -80°C, since repeated thawing crimps enzyme life. Some labs dial in additives like glycerol for even better shelf life.
Sortase A owes its popularity to the straightforward transpeptidation reaction. If your protein has the C-terminal LPXTG motif, and a labeling peptide carries an N-terminal oligoglycine, this enzyme stitches them together under mild conditions. Reactions usually need calcium ions, although engineered calcium-independent variants allow even greater flexibility. Modifying antibodies, attaching fluorophores, or assembling protein chimeras become nearly routine. Single-site specificity beats random NHS ester chemistry every time, and site-selectivity controls downstream bioactivity. Improvements in engineered variants boost reaction speeds or broaden sequence tolerance, but most workflows stick to the classic LPXTG-GGG system.
Sortase A sometimes appears under names like peptidylglycine transpeptidase, SrtA, or just “bacterial Sortase.” In the world of catalogs, it’s usually described as Sortase A (His-tag), sometimes with notes on origin or expression host. While companies tempt with proprietary formulations or buffer blends, core functionality remains wedded to that signature LPXTG cleavage and ligation.
Most groups treat Sortase A as a biosafe reagent. Because it derives from non-pathogenic sources and contains no live bacteria, it doesn’t pose biological risk in a typical lab. Standard PPE—gloves, eye protection, lab coats—covers most scenarios. Allergic reactions almost never feature in case studies. Disposal follows usual protein lab waste streams. While regulatory guidelines tighten around large-scale downstream applications, especially in clinical manufacturing, day-to-day research use fits comfortably within standard biosafety protocols. As always, good record-keeping and traceability for reagents form best practice, especially as this enzyme moves toward therapeutic production lines.
Sortase A turns up in protein engineering, surface modification, and conjugate vaccine development. Researchers learning about cell surface modifications gravitate toward this enzyme for its ability to anchor proteins neatly, even onto living cell membranes. Fluorescent labeling at a single, known residue improves imaging experiments, sharpening data in super-resolution microscopy. Antibody-drug conjugates rely on Sortase A for positioning linkers—achieving predictable payload ratios, something wild-type chemical reactions struggle with. Synthetic biologists assemble large protein scaffolds, using the enzyme to knit together modular parts. From diagnostics to therapeutics, Sortase A’s consistency supports research and commercial products alike.
Academic labs work overtime optimizing Sortase A mutations, crafting variants with faster reaction rates, improved substrate tolerance, or resistance to denaturing. Some groups push for activity at lower temperatures or in the absence of calcium, making this enzyme attractive for live-cell settings or sensitive protein targets. In pharma, scientists aim for GMP-compliant production, high-purity formulations, and clear regulatory pathways for enzyme-linked drugs. Research continually refines kinetic understanding—some focus on mechanistic studies, others look for new application frontiers in targeted drug delivery, immuno-oncology, and vaccine adjuvantation. Trends in enzyme immobilization or co-localization with nanoparticles widen possible uses, and open up new discovery doors.
Current knowledge places Sortase A firmly in the low-toxicity camp. Studies in animals and cultured cells show little risk, provided the enzyme stays outside living organisms or is later removed. Traces of endotoxin, possible from E. coli expression, come under scrutiny for therapeutic applications. Purification steps that remove these contaminants—using endotoxin-specific resins or detergents—become essential for clinical projects. Otherwise, routine handling in research settings doesn't raise red flags. Unintended immune responses, off-target reactions, or cellular toxicity have not emerged in published reports, supporting continued expansion in bioconjugation and therapeutic pathways.
Sortase A’s future tracks closely with synthetic biology and precision therapeutics. Engineering new variants already posts impressive results—improved substrate sequences, resistance to standard inhibitors, and temperature stability that allows industrial-scale protein modification. Integration with automated biomanufacturing can unlock new conjugated vaccines, smarter therapeutics, and on-demand biosensors. As companies move from animal models to human clinical trials, regulatory documentation and robust supply chains for high-purity, traceable enzyme preparations will shape future use. The push for greener, more sustainable chemistry also boosts enzymes like Sortase A, offering targeted modifications instead of blunt force chemicals. Ongoing support from the research, biotech, and pharmaceutical communities shows Sortase A has not peaked; its story continues, shaped by both technical breakthroughs and creative new research directions.
In the swirl of modern biotechnology, researchers hunt for tools that cut, paste, or glue proteins together with accuracy. Sortase A, an enzyme originally discovered in certain bacteria, steps up as one of those tools. Its main job in nature involves anchoring proteins to bacterial cell walls, but scientists spotted the opportunity to redirect its purpose. Now, in labs around the world, Sortase A—often paired with a polyhistidine (His) tag for easy handling—serves a variety of cutting-edge projects.
Sortase A acts like a molecular seamster. It recognizes a short tag, typically the LPXTG sequence, on a protein and snips right at that spot. Once it cuts, the enzyme stitches the protein to something else, usually another peptide or molecule with a special starting amino acid (glycine). The His-tag, a chain of histidine amino acids, works like a handle—researchers use it to pull Sortase A out of a mixture with simple lab tricks. This step keeps the process clean, which is gold when quality and accuracy matter.
Lab-made proteins often end up fused to other molecules, from fluorescent markers to drug carriers. Sortase A makes such links possible without the need for harsh chemicals that can wreck sensitive proteins. For example, in antibody-drug conjugates (ADCs), scientists use this enzyme to attach a cancer-fighting drug to an antibody. This precision boosts treatment strength and keeps healthy cells out of the line of fire. In my time consulting with a bio-pharma group, I watched researchers run the process over and over: Sortase A would do its work, and with the His-tag, cleanup came fast. Yields jumped, waste went down.
Industry leaders care about speed and safety as much as results. Sortase A (His-Tag) offers a straightforward route to protein modification. Academic labs, big pharma, and even startups use it to craft protein-based sensors, vaccines, or diagnostic tools. Unlike old-school chemical methods, the reaction runs at room temperature, in water, and leaves side products down to a minimum. That means fewer headaches—less fuss over purifying the final material, less worry about unexpected byproducts.
Not all proteins play nicely with enzymatic modification. Sometimes the LPXTG tag gets buried in a complex structure, hiding it from Sortase A. Protein engineering helps here; researchers can design variants with tags in better spots, or dial in the enzyme properties using advanced mutagenesis. There’s also the question of scale: Large-batch manufacturing sometimes struggles to match the efficiency seen in small lab setups. Companies are teaming up with academic groups to fine-tune reaction setups, enzyme concentrations, and purification steps to scale up reliably.
As protein-based therapeutics keep growing in demand, precision tools like Sortase A (His-Tag) will give researchers new ways to assemble complex drugs or diagnostics. Sharing data and best practices speeds the process, and ongoing studies into enzyme variants may soon stretch its range even further. In my encounters with academic partners, creative applications continue to emerge—each one testing the limits of what’s possible with this enzyme. For anyone tracking the future of molecular design or bioengineering, watching the progress around Sortase A promises plenty of inspiration.
Anyone working with recombinant proteins knows wasted time and money can easily come from small mistakes in storage or handling. Sortase A, especially with the His-Tag variant, is no exception. Good practice starts the moment you crack open that first microcentrifuge tube—smart habits make all the difference.
Sortase A arrives lyophilized or in buffered solution, and both forms ask for care. I remember a postdoc in my lab who left a freshly reconstituted aliquot on the bench. By the next day, activity had dropped by nearly half. Protein degradation can happen fast, and Sortase A isn’t immune. Cold storage matters. Sortase A stays stable for months at -80°C. At -20°C, you cut shelf life down, so -80°C should be the gold standard for long-term keeps. For those with only access to a standard lab freezer, sticks with using smaller aliquots and avoid freeze-thaw cycles as much as possible. This enzyme really hates repeated freezing and thawing, turning precious stocks into wasted resources.
Sortase A likes a neutral buffer, and imidazole can hang around from the purification, but you want that concentration below 50 mM. For stabilizers, many labs—mine included—turn to 10-50% glycerol. Glycerol does a solid job at reducing freeze-thaw damage. Once reconstituted, make small aliquots—maybe 20 to 50 µL per tube—so only as much as you need gets thawed and used. Keep the rest tucked away, undisturbed in the deep freeze.
I once watched my own careful labeling system save me headaches. With enzymes like Sortase A, you want clear dates and concentrations recorded on every tube. No sharpie on faulty stickers. Use tough lab tape or pre-printed cryotube labels. Indicate whether that aliquot contains glycerol. You might think you’ll remember, but busy weeks make memories foggy and errors pile up. I always write initials so the next person down the line knows who prepped that stock.
Pipetting out cold Sortase A, never let the enzyme linger at room temperature. Enzyme kinetics change with temperature, and so does denaturation risk. If it takes more than a couple of minutes to assemble your reaction, keep the enzyme tube on ice, closing the cap between uses. Any leftover enzyme goes right back into the freezer, never straight from room temperature—use that ice bucket religiously.
This enzyme works at low concentrations, so minor contaminants can cause big headaches. One time someone double-dipped a pipette tip, and the next batch had bacterial growth visible after two days. Always use new tips, especially if you share fridges with others. For group labs, rotating monthly visual checks of stored enzymes can catch cloudiness or crystal growth nobody noticed. Replace anything that looks suspicious.
Fixing temperature abuse comes from clear labeling of freezer racks and laying down ground rules about quick access. If low yield persists, check for the old imidazole buffer hangover or high freeze-thaw cycles. Collect pipetting tips in a designated container to cut cross-contamination. Some labs run monthly enzyme quality tests—an extra step, but it has saved entire projects from disaster. Harnessing these simple strategies translates to better results and dependable enzyme activity every time you open a tube.
Sortase A has become a go-to tool for protein engineering in academic and industry labs, thanks to its ability to neatly attach peptides or small protein tags to the surface of larger proteins. While this enzyme came out of bacterial biology, it has gained ground in bioconjugation strategies, diagnostic tool development, and even potential therapeutic applications. The real challenge: getting predictable, high-yield ligation with as little background as possible.
From personal troubleshooting and collaboration with fellow protein chemists, a few non-negotiables stand out. Freshly purified proteins and peptides always outperform those that have seen multiple freeze-thaw cycles. Mixing 80–100 μM substrate with 5–20 μM His-tagged Sortase A typically delivers the best balance of speed and resource management. In my hands, Tris-HCl buffer at pH 7.5, with 50 mM NaCl and 10 mM CaCl2, gives consistent performance. Calcium isn’t just window dressing; Sortase A activity drops off sharply without it.
Setting up the reaction at 4°C or room temperature for 1–3 hours encourages specificity, protecting your investment in purified protein. More time won’t always improve conversions, especially for sensitive protein targets that start to degrade. Once the reaction wraps up, nickel-NTA affinity purification helps to fish out the His-tagged enzyme and any unreacted His-tagged substrate. I’ve found this step especially useful for cleaning up reactions, as Sortase A’s His-tag means separation is a breeze.
A successful ligation depends not only on buffer and temperature. Concentration of your LPXTG-tagged protein and GGG-containing nucleophile plays a big role. Too much nucleophile can force the ligation cycle to run backward, a fact I learned after seeing product yields plateau far below expectations. UV or SDS-PAGE analysis gives a good snapshot of how far the reaction progressed. Mass spectrometry verification ensures the intended ligation, since minor side products sometimes hide under the radar until downstream steps reveal functional issues.
There’s a common misconception that any His-Tag Sortase protocol works right out of the box for every protein. In practice, protein folding and tag accessibility throw curveballs. Some fusion partners shield the LPXTG or GGG sequence, forcing you to play with linkers or rearrange domains. Lab experience shows subtle changes—moving a tag one residue or adding a flexible linker—can rescue a lagging reaction. The enzyme itself also tells a story: wild-type Sortase A sometimes acts sluggish outside the original pH or temperature window. Commercially available mutants, like Sortase A 5M, often run faster and tolerate wider conditions if the native version underperforms.
One big topic in recent conversations is sustainability and scalability. Solutions lie in engineering: mutant enzymes with better kinetics and specificity help limit side reactions and cut down on the amount of enzyme required. Recombinant production in E. coli keeps costs reasonable, but optimizing protocols to recover active enzyme after purification matters for researchers on a budget.
Tracking small changes in efficiency pays dividends, not just for research-grade bioconjugates, but for larger-scale projects that reach clinics or markets. Each experiment offers a lesson on buffer tweaks, tag sequence choices, and the practical value of quality control. Tuning these elements means getting the most out of Sortase A-mediated ligation, propelling discovery with fewer setbacks.
Sortase A (His-Tag) has earned a place on lab benches for a reason. Researchers in biochemistry and molecular biology reach for this enzyme when they want precision in protein engineering. With its reliable ability to cut and paste peptide bonds, Sortase A opens up options for protein labeling, antibody-drug conjugates, and many more complex tricks. Yet, none of this means much if purity and strong specific activity fall short. Both shape how well experiments work and how quickly answers arrive.
Contaminants mess with experiments and make results fuzzy. For Sortase A (His-Tag), a purity above 90% keeps background interference out of the way. Many vendors offer recombinant versions purified through nickel-affinity chromatography. This exploits the His-tag: the enzyme politely latches onto the resin, and impurities wash away. The end product steps off the column with most other proteins left behind.
SDS-PAGE readings for such enzyme batches usually show a single bright band near 25 kDa, but trace impurities can still sneak in. Those show up sometimes as faint bands—often less than 5% by densitometry. High purity isn’t just bragging rights. In reactions with tiny amounts of starting material or in vivo work, those contaminants add noise. I've seen side products derail otherwise solid reactions. When you want crystal-clear data—think high-resolution mass spectrometry or critical therapeutic applications—cheap enzymes with impurities create hassle and lost time. Choosing a highly pure preparation often pays back in reliability.
The label “high purity” doesn’t always mean plenty of working enzyme. Specific activity cuts through marketing talk. It tells you how much actual catalytic punch you get per milligram. For Sortase A (His-Tag), a specific activity north of 50 U/mg is considered healthy. This value can jump to 100 U/mg or more in the best batches.
Specific activity boils down to this: how much substrate does a certain amount of enzyme chew through in an hour? More activity saves you money and time because you won’t need loads of enzyme to finish a job. Commercial Sortase A mostly comes dialyzed against phosphate or Tris buffer at pH 7-8, which keeps it stable and lively. I’ve used batches where only micrograms managed efficient protein ligations in under an hour. Poor activity means weaker or slower results, forcing users to double down on enzyme or fiddle with other reaction conditions. This burns through budgets and patience alike.
Not all suppliers keep standards tight. Some omit detailed certificates of analysis, leaving users to guess about true purity and activity. Anyone investing serious time or money in a project should ask for batch-specific data—not just glossy catalog numbers. Simple test reactions, like monitoring the ligation of a short peptide, help spot duds early.
If results seem murky, buffer composition sometimes plays a role. Some buffers can inactivate Sortase A, especially with oxidizing agents or strong chelators. Keeping chewable calcium concentrations and a pH closer to 8 tends to keep the enzyme humming along.
Biotech keeps evolving, and so do enzyme prep standards. Vendors now roll out recombinant Sortase A engineered for higher activity and improved solubility. Some even optimize codons for E. coli expression to turbocharge yields. For labs that need extra confidence, running in-house purity checks with size-exclusion chromatography or mass spectrometry offers another line of defense.
The lesson here is simple: purity and specific activity shape how far your next set of experiments will go. Taking extra steps to check what you’re working with protects both time and reputation.
Research labs often chase efficient protein labeling methods. Sortase A continues to pop up for anyone working with site-specific conjugation of peptides. It works like a molecular glue, latching proteins to tags or additives with a simple cut-and-paste move. The big question: will Sortase A, sporting the convenient His-Tag, actually work on your target peptide or protein? Experience says it all comes down to the details—the sequence you’re working with, the conditions you set, and a few overlooked snags in compatibility.
Sortase A targets a clear sequence—LPXTG, where X stands for any amino acid. For the enzyme to recognize your substrate, this motif has to appear at the right end of your target (usually the C-terminus). If you try to run a reaction on a protein that skips this sequence, nothing meaningful will happen, no matter how pure or expensive your reagents. Peer-reviewed work, including articles like Chen et al., 2021 in Frontiers in Bioengineering, confirms that even small tweaks near this site may cut efficiency down dramatically.
Adding a His-Tag to Sortase A doesn’t move the goalposts for its activity but brings out big advantages in purification. His-Tags latch onto nickel columns, which means less time fussing with messy purification steps. That’s a lifesaver in crowded lab freezers, especially for larger projects or teaching labs. But once in action, the His-Tag usually hangs out away from Sortase A’s active site, so it rarely trips up the enzyme’s job. Still, always keep an eye out—big tags or extra linkers can twist up enzyme folding, sometimes tanking activity or causing the protein to crash out as an useless clump.
It’s not just about having LPXTG. The substrate’s flexibility, exposure of the tagging site, and nearby residues play real roles. Rigid or tucked-away motifs pose a huge challenge. Scientists like Popp and Ploegh (2011, ACS Chemical Biology) showed that accessibility often decides success, even if the sequence is perfect. I’ve hit this snag myself—some proteins almost never label, until a flexible linker opens up the tagging site.
Sortase A works best with calcium in the buffer, with pH leaning toward neutral. Without these basics, even the brightest green substrate won’t light up under the scanner. It can take a few gradient tests—tweaking molarities, swapping in additives, or even chilling the mix longer—to spot the happy medium for your peptide. That hands-on optimization saves precious project weeks, instead of blindly running through kits and frustration.
For researchers, the bottom line comes from bench results. Run a pilot test before scaling up, since even textbook setups sometimes flop with a new substrate. Talking with peers, sharing failed runs, and reading more than just the product tech sheets often points out unexpected pitfalls or creative solutions. As with most molecular tools, results tighten up as you build experience—sometimes with a few ruined gels along the way.
Protein conjugation gave labs the power to label, immobilize, or engineer peptides with a level of precision that once seemed out of reach. Sortase A—especially with a His-Tag—streamlines the workflow, but only for compatible substrates with accessible motifs. Open forums, detailed documentation, and regular troubleshooting can all help avoid costly mistakes, saving both time and grant money, one reaction at a time.
| Names | |
| Preferred IUPAC name | N-(6-aminohexanoyl)-L-histidyl-L-histidyl-L-histidyl-L-histidyl-L-histidyl-L-histidine-(Sortase A) |
| Other names |
SA SrtA Sortase A transpeptidase Sortase from Staphylococcus aureus |
| Pronunciation | /sɔːrˈteɪs eɪ hɪs tæg/ |
| Identifiers | |
| CAS Number | 1110242-12-0 |
| Beilstein Reference | 16219882 |
| ChEBI | CHEBI:140227 |
| ChEMBL | CHEMBL1743085 |
| ChemSpider | No ChemSpider |
| DrugBank | DB11375 |
| ECHA InfoCard | 07c8a399-bd6a-4c92-9f5b-feb88c5b813d |
| EC Number | 3.4.22.70 |
| KEGG | sce:850430 |
| MeSH | D000072680 |
| RTECS number | WKQ1EQ2K6T |
| UNII | 18KY0R865X |
| UN number | UN3179 |
| CompTox Dashboard (EPA) | CompTox Dashboard (EPA) of product 'Sortase A (His-Tag)' is: "DTXSID80156293 |
| Properties | |
| Chemical formula | C2941H4549N777O832S22 |
| Molar mass | 25339 Da |
| Appearance | White lyophilized powder |
| Odor | Odorless |
| Density | 1.21 g/cm³ |
| Solubility in water | Soluble in water |
| log P | -4.10 |
| Acidity (pKa) | 6.58 |
| Basicity (pKb) | 8.98 |
| Refractive index (nD) | 1.57 |
| Dipole moment | 0.0000 D |
| Pharmacology | |
| ATC code | V03AX |
| Hazards | |
| Main hazards | No known significant hazards. |
| GHS labelling | GHS labelling: Not a hazardous substance or mixture according to Regulation (EC) No. 1272/2008. |
| Pictograms | GHS07 |
| Signal word | Warning |
| Hazard statements | No Hazard Statements. |
| Precautionary statements | Precautionary statements: P261, P305+P351+P338 |
| NIOSH | Not classified |
| PEL (Permissible) | Not Established |
| REL (Recommended) | 50 µg |
| Related compounds | |
| Related compounds |
Sortase A Sortase A (Delta59) Sortase A (Staphylococcus aureus) Sortase B Sortase C Transpeptidase LPXTG motif peptide |
